Print

Russia First To Approve Merck KGaA (MKGAF.PK) Multiple Sclerosis Pill Cladribine  
7/12/2010 7:17:19 AM

FRANKFURT, July 12 (Reuters) - Russia is the first country to approve Merck KGaA's (MRCG.DE) new multiple sclerosis pill cladribine, giving the German drugmaker an edge in the emerging market against larger rival Novartis AG (NOVN.VX).